资讯

Managed Healthcare Executive

Povorcitinib Shows Hope for Patients with Hidradenitis Suppurativa in Phase 3 Trials

Povorcitinib shows promising results for hidradenitis suppurativa, offering significant lesion reduction and pain relief in ...